BioPharma Drug Discovery

Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox

 Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an investment pro...

 October 14, 2021 | News

BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery

 BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced the launch of the BD SCF™ PremiumCoat&re...

 October 13, 2021 | News

Luciole ,Cyclica to Accelerate Discovery of Novel Medicine

"Luciole aims to be the premier mitochondrial repair company by applying state-of-theart technology and an efficient, virtual company approach to developin...

 October 07, 2021 | News

South Korea Advances Treatment of Polymyositis

Immunoforge (Co-CEOs Sung-min Ahn, Kiho Chang), a company specializing in developing new drugs for rare musculoskeletal diseases, has reported that th...

 September 28, 2021 | News

Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002

Currently there are over 100 million of people with various degree of osteoporosis and 4 million people in China with severe osteoporos...

 September 27, 2021 | News

Mirum. Takeda to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan

Partnership leverages Takeda’s leadership in rare disease, gastroenterology, and hepatology to advance maralixibat in a major market   Mirum P...

 September 23, 2021 | News

Singapore Approved New Therapy to Treat Advanced Small Cell Lung Cancer

  ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20...

 September 23, 2021 | News

Happiness Biotech Announced The Launch of Its Lucidum Tablets

"To prevent false advertisement in the healthcare industry and prohibit defective health products from entering the market, China has set forth s...

 September 13, 2021 | News

Frontage Expands Early Drug Discovery Services through the Acquisition of Heyan Biotech

Heyan Biotech, located in Wuhan Optics Valley, national biotech industry base, provides for target based in vitro pharmacodynamic screening and early pharm...

 September 09, 2021 | News

Yiling Pharmaceutical's Yishen Yangxin Anshen Tablets Granted Drug Certificate

With the functions of reinforcing kidney, nourishing heart, and tranquilizing mind, this drug offers a new treatment for insomnia with the symptoms of slee...

 September 08, 2021 | News

GeneQuantum ,BrighGene to develop antibody immune agonist conjugates

GQ1007 is a new type of antibody-drug conjugate. It is an antibody conjugated to a potent immune agonist. In recent years, immunotherapeutic antibody drugs...

 September 07, 2021 | News

Insilico Medicine & 4B Technologies to advance the development of innovative small molecule therapies

Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery company, and 4B Technologies Co., Ltd. ("4B ...

 August 30, 2021 | News

Kintor Pharma Collaborates with Etana to Commercialize Proxalutamide to treat Covid19

Pursuant to the Licensing Agreement, Kintor Pharma will receive from Etana upfront and milestone payments, in addition to the economic benefit relating to ...

 August 26, 2021 | News

Study Confirms Viraleze Provides Protection Against SARS-CoV-2

The findings, published in the peer-reviewed journal Viruses, in a special issue titled Medical Interventions for Treatment and Prevention of SAR...

 August 24, 2021 | News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in